Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps

Approximately one third of epilepsy patients do not become seizure free with antiseizure medications. This treatment gap motivates research for new therapeutic options, such as cannabidiol (CBD). CBD differs from other cannabis derivatives because of its consistent efficacy and lack of a psychoactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Guilherme Diogo, Del Guerra, Felipe Borelli, de Oliveira Lelis, Maira, Pinto, Lécio Figueira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604476/
https://www.ncbi.nlm.nih.gov/pubmed/33192966
http://dx.doi.org/10.3389/fneur.2020.531939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604476/
https://www.ncbi.nlm.nih.gov/pubmed/33192966
http://dx.doi.org/10.3389/fneur.2020.531939

Ejemplares similares